Martin A. Mattingly - 10 Jun 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
Director
Signature
/s/ Scott B. Brown, Attorney-In-Fact
Issuer symbol
TCON
Transactions as of
10 Jun 2021
Transactions value $
$0
Form type
4
Filing time
24 Jun 2021, 19:01:28 UTC
Previous filing
13 May 2021
Next filing
01 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCON Director Stock Option (Right to Buy) Award $0 +10.5K $0.00 10.5K 10 Jun 2021 Common Stock 10.5K $6.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders.